Skip to main content
Fig. 2 | Chinese Medicine

Fig. 2

From: Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells

Fig. 2

The effects of gefitinib (Iressa) and HS7 on the proliferation of CL1-0 lung cancer cells. a The cell viability of CL1-0 cells was measured after treatment with gefitinib for 72 h. b The cell viability of CL1-0 cells was measured after treatment with HS7 for 72 h. c The effect of HS7 on CL1-0 cells was examined by phase-contrast microscopy after 72 h of treatment, scale bar = 100 μm. Cell viability data (mean ± SE) are expressed as a percentage compared to the control and analyzed as described in “Statistical analysis”. ***p < 0.001 compared to the control group

Back to article page

Chinese Medicine

ISSN: 1749-8546

Contact us